Letter: Methodological Caveats in Zhang et al.-Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2025-11-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/apt.70423PMID 41230823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression

  2025cited by this paper
• Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

  2017cited by this paper
• HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

  2016cited by this paper
• Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

  2014cited by this paper

• No citing papers are available for this paper.